Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
glenmark
1 Injection
Bortezomib
Keep in cold place
Delivering To:
Overview
Bortrac 2mg Injection is a targeted therapy-based anticancer medicine. It is prescribed to treat multiple myeloma and mantle-cell lymphoma in adult patients. The generic name of this medication is Bortezomib, and it is a novel proteasome inhibitor. It is commonly used in patients who have had two unsuccessful previous therapies. It is injected intravenously by a doctor or a trained nurse only.
Prostate Cancer
Side effects are undesirable symptoms that can result from any medical treatment. Like any other medicine, Bortrac 2mg Injection also causes some adverse impact on the body, most of which resolve without any medical attention.
Some common side effects include:
Constipation
Nausea
Vomiting
Loss of appetite
Stomach pain
Redness and swelling at the injection site
Dizziness
Tingling in hands and arms
Sore throat
Shortness of breath
Increased bleeding
Fever
Chills
Wheezing
Muscle cramps
Contact your healthcare provider if you face any unusual or persistent side effects.
Bortrac 2mg Injection is given by a doctor or trained nurse under strict medical supervision. It is not self-administerable. The dosage and duration of the treatment are determined by the doctor based on the patient's health condition.
Bortrac 2mg Injection is an anticancer medicine that belongs to the class of proteasome inhibitors. It works by blocking or slowing down the breakdown of protein (26S proteasome) in cells. It leads to the accumulation of protein in cancer cells, which ultimately causes cell death.
Alcohol
unsafe
Avoid the consumption of alcohol while taking Bortrac 2mg Injection, as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
Pregnancy
consult your doctor
Bortrac 2mg Injection is not recommended during pregnancy as it is unsafe for the developing fetus. Doctors rarely prescribe this medicine in pregnancy.
Breast Feeding
consult your doctor
Bortrac 2mg Injection is unsafe to use during breastfeeding as it may cause toxicity to the baby.
Driving
danger
Bortrac 2mg Injection may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.
Kidney
caution
Consumption of Bortrac 2mg Injection should be avoided without informing the doctor if you have any kidney-related issues.
Liver
caution
Consumption of Bortrac 2mg Injection tablet should be avoided without informing the doctor if you have any liver-related issues.
It is advisable to avoid missing any dose of Bortrac 2 but in case you miss a dose consult your doctor immediately.
Bortrac 2mg injection is an anticancer injection that is primarily used in the treatment of multiple myeloma and mantle-cell lymphoma.
Bortrac 2mg injection is given intravenously by a doctor or an experienced nurse as prescribed by the doctor.
It is advisable to store the Bortrac 2 vial in a place below 30°C.
It is advisable to avoid driving and operating heavy machinery as Bortrac 2 injection causes dizziness as one of the side effects.
Bortrac 2mg injection can cause harm to the fetus. Hence, it is advisable to avoid pregnancy or consult the doctor for the same.
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
1.https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215331s000lbl.pdf
2. Roccaro, A. M., Vacca, A., & Ribatti, D. (2006). Bortezomib in the treatment of cancer. Recent patents on anti-cancer drug discovery, 1(3), 397-403.
3. Kouroukis, T. C., Baldassarre, F. G., Haynes, A. E., Imrie, K., Reece, D. E., & Cheung, M. C. (2014). Bortezomib in multiple myeloma: systematic review and clinical considerations. Current oncology, 21(4), e573.
4. Mujtaba, T., & Dou, Q. P. (2011). Advances in the understanding of mechanisms and therapeutic use of bortezomib. Discovery medicine, 12(67), 471.
5. Jackson, G., Einsele, H., Moreau, P., & San Miguel, J. (2005). Bortezomib, a novel proteasome inhibitor, in the treatment of hematologic malignancies. Cancer treatment reviews, 31(8), 591-602.
glenmark
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.
Reviewed By
Dr. Aditya Sarin - MBBS, MD, DrNB - Consultant Medical Oncology
Dr. Aditya Sarin, MBBS, MD, DrNB, is a highly qualified medical oncologist with profound research and clinical expertise, currently working at Sir Ganga Ram Hospital, New Delhi. He is also a member of the European Society of Medical Oncology (ESMO), a non-profit European organization dedicated to eradicating cancer by promoting comprehensive cancer care and advancing medical oncology. He has been honored with several awards, including the International Cancer Foundation scholarship (ESMO congress, 2022) and Young Medical Oncologist of the Year (Times of India, 2024). He is well-known for his breakthrough in oncology. Dr. Sarin is passionate about converting complex health information into a concise and clear form that is understandable to everyone, aiming to create awareness and cancer care among people.